ADAM (Closed to Recruitment)
Acamprosate (Campral) may be prescribed to people who have had problems with alcohol to help reduce the risk of drinking again. Some people who take this medication may not receive the full benefit because they do not take the medication regularly or for long enough. This research aims to help support people to take acamprosate as it is prescribed using medication management and personal achievment awards.
To find out whether these are effective at helping people take acamprosate as prescribed, we want to compare the experiences of people getting the usual support for taking their acamprosate with those receiving additional medication management. We also want to compare those getting usual support with those receiving medication management plus a personal achievement award. We want to know if taking acamprosate as prescribed will help people remain off alcohol.
Who can be involved?
- Adults over 18 years of age
- Who have a diagnosis of alcohol dependence but who are currently alcohol abstinent
- Prescribed acamprosate by treating clinician
What happens to people taking part in this research?
This study is a randomised controlled trial so some patients will receive usual care, some will recieve usual care plus medicines management and some will recieve usual care, medicines management and personal achievement awards.
The new interventions will be delivered over the telephone in 12 sessions over 6 months.
This study has now closed to recruitment. We are currently awaiting results. In the meantime if you would like to find out more please complete the following form: